Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at ...
A new human liver organoid platform could help predict which drugs trigger dangerous immune reactions in susceptible patients ...
Fate Therapeutics, Inc. (NASDAQ: FATE) (the Company), a clinical-stage biopharmaceutical company dedicated to bringing a ...
With iPSCs continuing to emerge as an important source of starting materials for cell therapy developers, it is crucial to ...
Brian O'Driscoll was speaking at the Cyber Leader Summit in Dublin when he was interrupted by pro-Palestine activists who ...
About Century Therapeutics Century Therapeutics (NASDAQ: IPSC) is a clinical-stage biotechnology company advancing a pipeline of induced pluripotent stem cell (iPSC)-derived cell therapies with the ...
Pro-Palestinian activists have said that they are going to continue taking to the streets in the wake of the ceasefire in ...
Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation ...
Fate Therapeutics ( ($FATE) ) has issued an announcement. On October 10, 2025, John D. Mendlein and Neelufar Mozaffarian resigned from Fate ...
The brain's mechanisms for repairing injuries caused by trauma or degenerative diseases are not yet known in detail. Now, a ...